Lily is a trainee attorney in the Melbourne Biotechnology group who uses her multifaceted scientific, legal and commercial experience to provide exceptional results for her clients.
Following completion of her Bachelor of Science (double major in biochemistry and biotechnology) at the University of Melbourne, and Honours at the Peter MacCallum Cancer Institute, Lily went on to complete her PhD at the Walter & Eliza Hall Institute in 2016. Lily’s research involved the examination of molecular mechanisms contributing to an aggressive subtype of breast cancer and provided insights into the complexities of hormone receptor-negative cancers. Her research was completed in collaboration with a US multinational biopharmaceutical company. Prior to completing her PhD, Lily worked as a research technician at the Walter & Eliza Hall Institute, where she contributed to two high impact publications on understanding the mechanism of programmed cell death and ways this understanding can be used to treat cancer.
Lily has also worked as a paralegal and completed a Bachelor of Laws (with Honours) at the University of Melbourne in 2004 majoring in commercial and IP law. Lily’s extensive scientific and legal education and her commercial focus enables her to understand her clients’ needs.
Lily has co-authored numerous articles that have been published in renowned journals and received several PhD scholarship awards.